US4981692A
(en)
*
|
1983-03-24 |
1991-01-01 |
The Liposome Company, Inc. |
Therapeutic treatment by intramammary infusion
|
JPS6072831A
(ja)
*
|
1983-09-29 |
1985-04-24 |
Kao Corp |
ベシクル用組成物
|
FR2553002B1
(fr)
*
|
1983-10-06 |
1992-03-27 |
Centre Nat Rech Scient |
Procede perfectionne d'obtention de liposomes unilamellaires de diametres eleves, leur application pharmacologique pour l'encapsulage d'un principe actif en vue de son administration extemporanee et dispositif correspondant
|
US5231112A
(en)
*
|
1984-04-12 |
1993-07-27 |
The Liposome Company, Inc. |
Compositions containing tris salt of cholesterol hemisuccinate and antifungal
|
US4891208A
(en)
*
|
1985-04-10 |
1990-01-02 |
The Liposome Company, Inc. |
Steroidal liposomes
|
US4721612A
(en)
*
|
1984-04-12 |
1988-01-26 |
The Liposome Company, Inc. |
Steroidal liposomes
|
DE3421468A1
(de)
*
|
1984-06-08 |
1985-12-19 |
Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim |
Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
CA1270198A
(en)
*
|
1984-08-08 |
1990-06-12 |
Marcel B. Bally |
Encapsulation of antineoplastic agents in liposomes
|
US5736155A
(en)
*
|
1984-08-08 |
1998-04-07 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
US4761288A
(en)
*
|
1984-09-24 |
1988-08-02 |
Mezei Associates Limited |
Multiphase liposomal drug delivery system
|
US4897269A
(en)
*
|
1984-09-24 |
1990-01-30 |
Mezei Associates Limited |
Administration of drugs with multiphase liposomal delivery system
|
US5314642A
(en)
*
|
1984-11-27 |
1994-05-24 |
Igen, Inc. |
Interaction system comprising a surfactant-stabilized aqueous phase containing an antibody fragment
|
US5340587A
(en)
*
|
1985-05-22 |
1994-08-23 |
Liposome Technology, Inc. |
Liposome/bronchodilator method & System
|
US5192528A
(en)
*
|
1985-05-22 |
1993-03-09 |
Liposome Technology, Inc. |
Corticosteroid inhalation treatment method
|
JPH0688911B2
(ja)
*
|
1985-06-06 |
1994-11-09 |
国立予防衛生研究所長 |
インフルエンザワクチン及びその製造方法
|
DE3529175A1
(de)
*
|
1985-08-14 |
1987-02-19 |
Gft Ingenieurbuero |
Vorrichtung zur trennung von gemischen mittels des pervaporationsverfahrens
|
US4861580A
(en)
*
|
1985-10-15 |
1989-08-29 |
The Liposome Company, Inc. |
Composition using salt form of organic acid derivative of alpha-tocopheral
|
US5041278A
(en)
*
|
1985-10-15 |
1991-08-20 |
The Liposome Company, Inc. |
Alpha tocopherol-based vesicles
|
DE3542773A1
(de)
*
|
1985-12-04 |
1987-06-11 |
Roehm Pharma Gmbh |
Hautwirksame pharmaka mit liposomen als wirkstofftraeger
|
ES2039229T3
(es)
*
|
1986-01-14 |
1993-09-16 |
De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur |
Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos.
|
US5252263A
(en)
*
|
1986-06-16 |
1993-10-12 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
DE3635506A1
(de)
*
|
1986-10-18 |
1988-04-28 |
Mpi Medizinische Und Pharmazeu |
Verfahren zur herstellung liposomal eingeschlossener wirkstoffe unter verwendung von aus amphiphilen substanzen hergestellten liposomen
|
US5049388A
(en)
*
|
1986-11-06 |
1991-09-17 |
Research Development Foundation |
Small particle aerosol liposome and liposome-drug combinations for medical use
|
US5094785A
(en)
*
|
1986-12-10 |
1992-03-10 |
Ciba Corning Diagnostics Corp. |
Process for stabilizing liposomes
|
CA1323306C
(en)
*
|
1987-03-05 |
1993-10-19 |
Mircea C. Popescu |
Pharmacological agent-lipid solution preparation
|
US5154930A
(en)
*
|
1987-03-05 |
1992-10-13 |
The Liposome Company, Inc. |
Pharmacological agent-lipid solution preparation
|
MX9203808A
(es)
*
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
US5000960A
(en)
*
|
1987-03-13 |
1991-03-19 |
Micro-Pak, Inc. |
Protein coupling to lipid vesicles
|
US5023086A
(en)
*
|
1987-03-13 |
1991-06-11 |
Micro-Pak, Inc. |
Encapsulated ionophore growth factors
|
US4855090A
(en)
*
|
1987-03-13 |
1989-08-08 |
Micro-Pak, Inc. |
Method of producing high aqueous volume multilamellar vesicles
|
US4917951A
(en)
*
|
1987-07-28 |
1990-04-17 |
Micro-Pak, Inc. |
Lipid vesicles formed of surfactants and steroids
|
US5234767A
(en)
*
|
1987-03-13 |
1993-08-10 |
Micro-Pak, Inc. |
Hybrid paucilamellar lipid vesicles
|
US5628936A
(en)
*
|
1987-03-13 |
1997-05-13 |
Micro-Pak, Inc. |
Hybrid paucilamellar lipid vesicles
|
US4942038A
(en)
*
|
1987-03-13 |
1990-07-17 |
Micro Vesicular Systems, Inc. |
Encapsulated humectant
|
US4911928A
(en)
*
|
1987-03-13 |
1990-03-27 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
US4853228A
(en)
*
|
1987-07-28 |
1989-08-01 |
Micro-Pak, Inc. |
Method of manufacturing unilamellar lipid vesicles
|
US4963362A
(en)
*
|
1987-08-07 |
1990-10-16 |
Regents Of The University Of Minnesota |
Freeze-dried liposome mixture containing cyclosporin
|
HU203204B
(en)
*
|
1987-09-15 |
1991-06-28 |
Sandoz Ag |
Process for producing suppository containing calcitonin and taurocholic acid
|
US4946683A
(en)
*
|
1987-11-18 |
1990-08-07 |
Vestar, Inc. |
Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
|
US5376381A
(en)
*
|
1988-02-25 |
1994-12-27 |
The Liposome Company, Inc. |
Integrity protected gelatin
|
US5032457A
(en)
*
|
1988-03-03 |
1991-07-16 |
Micro Vesicular Systems, Inc. |
Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants
|
US5019392A
(en)
*
|
1988-03-03 |
1991-05-28 |
Micro-Pak, Inc. |
Encapsulation of parasiticides
|
US5019174A
(en)
*
|
1988-03-03 |
1991-05-28 |
Micro Vesicular Systems, Inc. |
Removing oil from surfaces with liposomal cleaner
|
US5160669A
(en)
*
|
1988-03-03 |
1992-11-03 |
Micro Vesicular Systems, Inc. |
Method of making oil filled paucilamellar lipid vesicles
|
US5104736A
(en)
*
|
1988-03-03 |
1992-04-14 |
Micro-Pak, Inc. |
Reinforced paucilamellar lipid vesicles
|
MX9203504A
(es)
*
|
1988-04-20 |
1992-07-01 |
Liposome Co Inc |
Complejo agente: lipido activo de alta proporcion.
|
WO1989011335A1
(en)
*
|
1988-05-17 |
1989-11-30 |
Liposome Technology, Inc. |
Preparation of uniform-size liposomes and other lipid structures
|
US5000887A
(en)
*
|
1988-05-17 |
1991-03-19 |
Liposome Technology, Inc. |
Preparation of uniform-size liposomes
|
US4994213A
(en)
*
|
1988-05-17 |
1991-02-19 |
Liposome Technology, Inc. |
Method of preparing lipid structures
|
DE68916956T2
(de)
*
|
1988-05-20 |
1994-11-24 |
Liposome Co Inc |
Aktives mittel: lipid-komplex mit hohem verhältnis.
|
US4937078A
(en)
*
|
1988-08-26 |
1990-06-26 |
Mezei Associates Limited |
Liposomal local anesthetic and analgesic products
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
US5227165A
(en)
*
|
1989-11-13 |
1993-07-13 |
Nova Pharmaceutical Corporation |
Liposphere delivery systems for local anesthetics
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
US5221535A
(en)
*
|
1989-11-13 |
1993-06-22 |
Nova Pharmaceutical Corporation |
Sustained release formulations of insect repellent
|
ATE138803T1
(de)
*
|
1990-07-31 |
1996-06-15 |
Liposome Co Inc |
Anhäufung von aminosäuren und peptiden in liposomen
|
DE69120543T2
(de)
*
|
1990-09-06 |
1997-01-09 |
Johnson & Son Inc S C |
Verfahren zur stabilisierung von liposomen sowie diese enthaltende mittel
|
US5753258A
(en)
*
|
1990-10-19 |
1998-05-19 |
University Of Florida |
Artificial viral envelopes
|
ATE132034T1
(de)
*
|
1990-10-19 |
1996-01-15 |
Univ Florida |
Künstliche virushüllen
|
US5213805A
(en)
*
|
1991-07-25 |
1993-05-25 |
Micro Vesicular Systems, Inc. |
Lipid vesicles having n,n-dimethylamide derivatives as their primary lipid
|
US5260065A
(en)
*
|
1991-09-17 |
1993-11-09 |
Micro Vesicular Systems, Inc. |
Blended lipid vesicles
|
FR2681247B1
(fr)
*
|
1991-09-17 |
1993-12-03 |
Oreal |
Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation.
|
US5405615A
(en)
*
|
1991-09-17 |
1995-04-11 |
Micro Vesicular Systems, Inc. |
Sucrose distearate lipid vesicles
|
US5324436A
(en)
*
|
1991-12-13 |
1994-06-28 |
The Administrators Of The Tulane Educational Fund |
Use of hydrate formation to control membrane mimetic systems
|
US5981501A
(en)
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
IL122290A0
(en)
*
|
1995-06-07 |
1998-04-05 |
Inex Pharmaceuticals Corp |
Lipid-nucleic acid complex its preparation and use
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
US20040208922A1
(en)
*
|
1995-06-07 |
2004-10-21 |
The Regents Of The University Of California |
Method for loading lipid like vesicles with drugs or other chemicals
|
US5705385A
(en)
*
|
1995-06-07 |
1998-01-06 |
Inex Pharmaceuticals Corporation |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
US6284375B1
(en)
*
|
1996-10-18 |
2001-09-04 |
Tuo Jin |
Lipid vesicle system
|
EP1027033B1
(en)
|
1997-05-14 |
2009-07-22 |
The University Of British Columbia |
High efficiency encapsulation of nucleic acids in lipid vesicles
|
SE9703302D0
(sv)
*
|
1997-09-10 |
1997-09-10 |
Vincenzo Vassarotti |
Filtration cell for tangential flow filtration and filtration system making use of such cell
|
US20040077603A1
(en)
*
|
1998-08-28 |
2004-04-22 |
Wilhelm Stoffel |
Synthetic tear fluid
|
US6855296B1
(en)
|
1998-11-13 |
2005-02-15 |
Optime Therapeutics, Inc. |
Method and apparatus for liposome production
|
DE69938875D1
(ja)
|
1998-11-13 |
2008-07-17 |
William A Heriot |
|
US7186331B2
(en)
*
|
2001-03-06 |
2007-03-06 |
Sasol Technology (Pty) Limited |
Monitoring unit for monitoring the condition of a semi-permeable membrane
|
US20030077829A1
(en)
*
|
2001-04-30 |
2003-04-24 |
Protiva Biotherapeutics Inc.. |
Lipid-based formulations
|
JP2005516897A
(ja)
*
|
2001-11-07 |
2005-06-09 |
イネックス ファーマシューティカルズ コーポレイション |
改善された粘膜のワクチン及びその使用方法
|
US20040082521A1
(en)
*
|
2002-03-29 |
2004-04-29 |
Azaya Therapeutics Inc. |
Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
|
US20040009944A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Methylated immunostimulatory oligonucleotides and methods of using the same
|
US7901708B2
(en)
|
2002-06-28 |
2011-03-08 |
Protiva Biotherapeutics, Inc. |
Liposomal apparatus and manufacturing methods
|
EP1648519B1
(en)
*
|
2003-07-16 |
2014-10-08 |
Protiva Biotherapeutics Inc. |
Lipid encapsulated interfering rna
|
US7803397B2
(en)
*
|
2003-09-15 |
2010-09-28 |
Protiva Biotherapeutics, Inc. |
Polyethyleneglycol-modified lipid compounds and uses thereof
|
AU2004280143A1
(en)
*
|
2003-10-11 |
2005-04-21 |
Tekmira Pharmaceuticals Corporation |
Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
|
US8592219B2
(en)
*
|
2005-01-17 |
2013-11-26 |
Gyros Patent Ab |
Protecting agent
|
AU2005251403B2
(en)
|
2004-06-07 |
2011-09-01 |
Arbutus Biopharma Corporation |
Cationic lipids and methods of use
|
AU2005252273B2
(en)
|
2004-06-07 |
2011-04-28 |
Arbutus Biopharma Corporation |
Lipid encapsulated interfering RNA
|
CA2572439A1
(en)
*
|
2004-07-02 |
2006-01-12 |
Protiva Biotherapeutics, Inc. |
Immunostimulatory sirna molecules and uses therefor
|
WO2006007712A1
(en)
*
|
2004-07-19 |
2006-01-26 |
Protiva Biotherapeutics, Inc. |
Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents
|
WO2006053430A1
(en)
*
|
2004-11-17 |
2006-05-26 |
Protiva Biotherapeutics, Inc. |
Sirna silencing of apolipoprotein b
|
WO2006075965A1
(en)
*
|
2005-01-17 |
2006-07-20 |
Gyros Patent Ab |
A method for detecting an at least bivalent analyte using two affinity reactants
|
US20070054873A1
(en)
*
|
2005-08-26 |
2007-03-08 |
Protiva Biotherapeutics, Inc. |
Glucocorticoid modulation of nucleic acid-mediated immune stimulation
|
EP1937252B1
(en)
*
|
2005-09-19 |
2017-10-25 |
Neuronascent, Inc. |
Compositions for stimulating neurogenesis and inhibiting neuronal degeneration
|
WO2007051303A1
(en)
|
2005-11-02 |
2007-05-10 |
Protiva Biotherapeutics, Inc. |
MODIFIED siRNA MOLECULES AND USES THEREOF
|
US7915399B2
(en)
|
2006-06-09 |
2011-03-29 |
Protiva Biotherapeutics, Inc. |
Modified siRNA molecules and uses thereof
|
CN101842100A
(zh)
|
2007-06-21 |
2010-09-22 |
诺伊罗纳森特公司 |
使用异噻唑并嘧啶酮刺激神经发生和抑制神经元变性的方法和组合物
|
EP2078556A3
(de)
*
|
2008-01-14 |
2009-08-19 |
PS Prozesstechnik GmbH |
Verfahren und Vorrichtung zur Filtration von Produktgemischen
|
CN102119217B
(zh)
*
|
2008-04-15 |
2015-06-03 |
普洛体维生物治疗公司 |
用于核酸递送的新型制剂
|
CA2740000C
(en)
|
2008-10-09 |
2017-12-12 |
Tekmira Pharmaceuticals Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
WO2011000106A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Improved cationic lipids and methods for the delivery of therapeutic agents
|
CA2767127A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for delivery of therapeutic agents to solid tumors
|
US9018187B2
(en)
|
2009-07-01 |
2015-04-28 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
WO2011148207A1
(en)
|
2010-05-28 |
2011-12-01 |
Diagon Kft. |
Procedure for biphasic preparation of liposomes and application thereof in manufacturing diagnostic reagents
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
EP3054936B1
(en)
|
2013-10-10 |
2023-10-18 |
Eastern Virginia Medical School |
4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives as 12-lipoxygenase inhibitors
|
US11013905B2
(en)
|
2017-05-11 |
2021-05-25 |
Tci Llc |
Thermal interconnect for implantable blood pump
|
CN117098541A
(zh)
|
2020-11-25 |
2023-11-21 |
阿卡格拉医药公司 |
用于递送核酸的脂质纳米粒及相关使用方法
|
WO2023056368A1
(en)
|
2021-09-30 |
2023-04-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cyclic peptides as non-hormonal male contraceptive agents and methods of use thereof
|
WO2023140901A1
(en)
|
2022-01-21 |
2023-07-27 |
Elanco Us Inc. |
Molidustat formulations and methods of use for treatment of anemia in cats
|